Elevance Health, INC Form 4 insider transactions

Director Robert L. Dixon Jr. reports acquisition of deferred stock units in Elevance Health, Inc.

Director Susan D. DeVore reported the acquisition of deferred stock units in Elevance Health, Inc.

Director Kerry Clark acquired 388 deferred stock units of Elevance Health on May 15, 2024, according to a Form 4 filing.

Felicia Norwood, EVP & President of Government Health Benefits at Elevance Health, reports the exercise of stock options and subsequent sale of shares.

Elevance Health's EVP & President, Commercial, Charles Morgan Kendrick JR, sold 2,432 shares of common stock at $500.46 per share on March 8, 2024.

Ronald W. Penczek, CAO & Controller of Elevance Health, Inc., reported selling 916 shares of common stock on March 6, 2024.

Ronald Penczek, CAO & Controller of Elevance Health, reports acquisition and disposal of common stock and derivative securities, including stock options and restricted share units, in a recent SEC Form 4 filing.

Elevance Health's EVP, CLO & CAO, Blair Williams Todt, reports acquisition and disposal of company stock and stock options on March 1, 2024.

Ratnakar Lavu, EVP & Chief Digital Officer of Elevance Health, reports the acquisition of stock and option awards.

Elevance Health's EVP & President, Commercial, Charles Morgan Kendrick JR, reports acquisition and disposal of company stock and stock options on March 1, 2024.

Felicia F. Norwood, an EVP & President at Elevance Health, reported the acquisition and disposal of company stock and stock options on March 1, 2024.

Elevance Health's EVP & President Carelon & CarelonRx, Peter D Haytaian, reports acquisition and disposal of company stock, including transactions related to option exercises and tax liability coverage.

Elevance Health's EVP & CFO, Mark Kaye, reports acquisition of common stock and employee stock options on March 1, 2024.

Elevance Health's CEO, Gail Boudreaux, reports the acquisition and disposal of company stock and stock options, including transactions related to tax liability and vesting of restricted stock.